| Name | SARS-CoV-2 nsp13-IN-2 |
|---|---|
| Synonyms |
SS-CoV-2 nsp13-IN-2
1-{4-[(1,3-benzothiazol-2-ylsulfanyl)methyl]-6-oxo-1,6-dihydropyrimidin-2-yl}-3-(4-methylphenyl)guanidine Guanidine, N-[4-[(2-benzothiazolylthio)methyl]-1,6-dihydro-6-oxo-2-pyrimidinyl]-N'-(4-methylphenyl) |
| Description | SARS-CoV-2 nsp13-IN-2 (Compound C2) is a SARS-CoV-2 non-structural protein 13 (nsp13) small-molecule inhibitor with an IC50 of 42 μM against nsp13 ssDNA+ ATPase[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 42 μM (nsp13 ssDNA+ ATPase)[1] |
| References |
| Molecular Formula | C20H18N6OS2 |
|---|---|
| Molecular Weight | 422.53 |